What is the price target for DRMA stock?
7 analysts have analysed DRMA and the average price target is 10.2 USD. This implies a price increase of 757.14% is expected in the next year compared to the current price of 1.19.
DERMATA THERAPEUTICS INC (DRMA) Forecast, Price Target & Analyst Ratings
NASDAQ:DRMA • US2498455045
Current stock price
1.19 USD
-0.05 (-4.03%)
At close:
1.19 USD
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DERMATA THERAPEUTICS INC (DRMA).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Mar 17, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$1.57
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$10.20
Upside
+ 757.14%
From current price of $1.19 to mean target of $10.20, Based on 7 analyst forecasts
Low
$10.10
Median
$10.20
High
$10.50
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for DRMA. The average price target is 10.2 USD. This implies a price increase of 757.14% is expected in the next year compared to the current price of 1.19.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
DRMA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about DRMA.
In the previous month the buy percentage consensus was at a similar level.
DRMA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-08-21 | Maxim Group | Maintains | Buy -> Buy |
| 2025-05-21 | Maxim Group | Maintains | Buy -> Buy |
| 2024-08-21 | Maxim Group | Maintains | Buy -> Buy |
| 2023-03-23 | Maxim Group | Maintains | Buy |
| 2021-09-21 | Brookline Capital | Initiate | Buy |
| 2021-09-14 | Maxim Group | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 17, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$1.57
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- 92.37%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
DRMA is expected to report earnings on 3/17/2026. The consensus EPS estimate for the next earnings is -1.57 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | |||||||
| EBITDA YoY % growth | -4.469M | -3.173M 29.01% | -7.857M -147.65% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -4.471M | -3.173M 29.03% | -7.857M -147.63% | -9.675M -23.13% | -8.042M 16.88% | -12.513M -55.60% | N/A 36.16% | N/A -23.42% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2,208.00 67.61% | -547.50 75.20% | -153.30 72.00% | N/A 94.68% | N/A 62.38% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.57 92.37% | -0.73 83.68% | -0.86 48.39% | -0.86 48.07% | -0.66 57.79% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -1.998M 37.56% | -2.186M 6.58% | -2.492M -40.57% | -2.552M -44.94% | -2.63M -31.60% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
DERMATA THERAPEUTICS INC / DRMA Forecast FAQ
What is the next earnings date for DRMA stock?
DERMATA THERAPEUTICS INC (DRMA) will report earnings on 2026-03-17, after the market close.
Can you provide the consensus estimates for DERMATA THERAPEUTICS INC next earnings?
The consensus EPS estimate for the next earnings of DERMATA THERAPEUTICS INC (DRMA) is -1.57 USD and the consensus revenue estimate is 0 USD.